Innate Pharma Growth Metrics (2018-2025) | IPHA

Growth Metrics Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -18008.0019,349.00-1801.00-31617.00-40531.00
EBITDA Margin Growth (3y) (Quarter) -460.00-22984.00
EBIT Margin Growth (1y) (Quarter) -18008.0019,349.00-1801.00-31617.00-40531.00
EBIT Margin Growth (3y) (Quarter) -460.00-22984.00
EBT Margin Growth (1y) (Quarter) -18262.0018,400.00-1448.00-30022.00-37736.00
EBT Margin Growth (3y) (Quarter) -1311.00-20784.00
Enterprise Value Growth (1y) (Quarter) -39.87%-26.69%-86,224.56%25.37%99.88%24.17%27.69%24.47%16.41%3.92%10.14%13.24%17.29%53.73%
Enterprise Value Growth (3y) (Quarter) -9.76%10.50%8.18%24.67%90.92%18.06%18.41%14.29%14.67%27.21%
Enterprise Value Growth (5y) (Quarter) 5.41%12.25%10.28%18.65%77.65%26.07%
FCF Margin Growth (1y) (Quarter) -14231.0020,059.00-3470.00-2977.001,052.00
FCF Margin Growth (3y) (Quarter) 2,851.0018,134.00
Interest Coverage Ratio Growth (1y) (Quarter) -78.29%965.87%-0.59%-56.91%2,994.25%162.33%-28.84%24.66%
Interest Coverage Ratio Growth (3y) (Quarter) 32.00%-39.75%65.90%3.96%12.11%
Interest Coverage Ratio Growth (5y) (Quarter) 21.06%36.94%71.72%
Net Margin Growth (1y) (Quarter) -7438.0037,071.00215.00-2069.00-30022.00-34735.00
Net Margin Growth (3y) (Quarter) 27,564.00267.00
Operating Margin Growth (1y) (Quarter) -31617.00
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.00-1.00-1.00-1.00
Return on Assets Growth (3y) (Quarter) 0.000.000.000.00-1.00-1.00
Return on Assets Growth (5y) (Quarter) -1.00-1.00
Return on Capital Employed Growth (1y) (Quarter) 311.00-1446.00-143.00-5002.00-12922.00-28618.00
Return on Capital Employed Growth (3y) (Quarter) -1551.00-6137.00-35066.00
Return on Equity Growth (1y) (Quarter) -1.00-1.000.001.000.000.00-1.00-4.00-14.0015.00
Return on Equity Growth (3y) (Quarter) 0.000.000.00-4.00-14.0011.00
Return on Equity Growth (5y) (Quarter) -15.0011.00
Return on Sales Growth (1y) (Quarter) 1.000.000.000.00-3.00-4.00
Return on Sales Growth (3y) (Quarter) 1.00-4.00